Construction of a Co-Expression Network for LncRNAs and MRNAs Related to Urothelial Carcinoma of the Bladder Progression

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Mar 14

PMID 35280820

Authors

Yeqing Mao

Chao Wen

Zitong Yang

Affiliations

Soon will be listed here.

Abstract

Carcinoma of urinary bladder is the most familiar cancer of the urinary tract, with the highest incidence in men. However, its prognosis and treatment have not improved significantly in the last 30 years. The main reason for this may be related to the alteration and regulation of genes. These alterations in genes that play a crucial role in cell cycle regulation may result in high-grade tumors and may alter drug sensitivity. Notably, the role of lncRNA in bladder cancer, especially the lncRNA-mRNA regulatory network, has not been fully elucidated. In this manuscript, we compared RNA sequencing (RNA-seq) data from 19 normal bladder tissues and 411 primary bladder tumor tissues using The Cancer Genome Atlas (TCGA) data bank, subjected differentially expressed mRNAs and lncRNAs to weighted gene co-expression network analysis, and screened out modules highly correlated with tumor progression. Subsequently, a lncRNA-mRNA co-expression network was built, and two key mRNAs were identified COX regression analysis. Kaplan-Meier curve analysis revealed that the overall survival of sick people in the high-risk section was significantly shorter than those in the low-risk section. Therefore, this lncRNA-mRNA-based co-expression pattern may be used clinically to predict the prognosis of carcinoma of urinary bladder people. Our study not only provides a genetic target for carcinoma of urinary bladder therapy but also provides new ideas for people in the medical profession to discover the treatment of various tumors.

Citing Articles

Effect of Curcumin on Hepatic mRNA and lncRNA Co-Expression in Heat-Stressed Laying Hens.

Wu X, Du X, Pian H, Yu D Int J Mol Sci. 2024; 25(10).

PMID: 38791430 PMC: 11121607. DOI: 10.3390/ijms25105393.

Elevated galectin-3 levels detected in women with hyperglycemia during early and mid-pregnancy antagonizes high glucose - induced trophoblast cells apoptosis via galectin-3/foxc1 pathway.

Deng Y, Jin H, Ning J, Cui D, Zhang M, Yang H Mol Med. 2023; 29(1):115.

PMID: 37626284 PMC: 10463409. DOI: 10.1186/s10020-023-00707-5.

Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients.

Huang X, Wang H, Huang S Front Genet. 2022; 13:906880.

PMID: 36061188 PMC: 9428265. DOI: 10.3389/fgene.2022.906880.

References

Chen C, Wang P, Mo W, Zhang Y, Zhou W, Deng T . Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA). J Cancer. 2019; 10(19):4707-4718. PMC: 6746144. DOI: 10.7150/jca.31234. View

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

Orom U, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G . Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010; 143(1):46-58. PMC: 4108080. DOI: 10.1016/j.cell.2010.09.001. View

Jordan E, Iyer G . Targeted therapy in advanced bladder cancer: what have we learned?. Urol Clin North Am. 2015; 42(2):253-62, ix. PMC: 4939834. DOI: 10.1016/j.ucl.2015.01.006. View

Chen M, Zhang R, Lu L, Du J, Chen C, Ding K . LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Aging (Albany NY). 2020; 12(21):22291-22312. PMC: 7695393. DOI: 10.18632/aging.202203. View

Romero-Barrios N, Legascue M, Benhamed M, Ariel F, Crespi M . Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018; 46(5):2169-2184. PMC: 5861421. DOI: 10.1093/nar/gky095. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Guo X, Gao L, Liao Q, Xiao H, Ma X, Yang X . Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res. 2012; 41(2):e35. PMC: 3554231. DOI: 10.1093/nar/gks967. View

Wu F, Lin Y, Cui P, Li H, Zhang L, Sun Z . Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner. Cancer Chemother Pharmacol. 2018; 81(6):999-1006. DOI: 10.1007/s00280-018-3578-8. View

10.

Zhuang L, Yang Z, Meng Z . Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. Biomed Res Int. 2018; 2018:7897346. PMC: 6186344. DOI: 10.1155/2018/7897346. View

11.

Chen C, Liu C, Cha T, Hsu C, Chou Y, Wu S . Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?. J Chin Med Assoc. 2015; 78(8):469-74. DOI: 10.1016/j.jcma.2015.05.003. View

12.

Ruff S, Ayabe R, Malekzadeh P, Good M, Wach M, Gonzales M . MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. J Surg Res. 2019; 243:1-7. PMC: 7478339. DOI: 10.1016/j.jss.2019.04.086. View

13.

Choi J, Kim Y, Lee J, Kim Y . High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer. Virchows Arch. 2013; 463(5):681-7. DOI: 10.1007/s00428-013-1473-6. View

14.

Li L, Peng Q, Gong M, Ling L, Xu Y, Liu Q . Using lncRNA Sequencing to Reveal a Putative lncRNA-mRNA Correlation Network and the Potential Role of PCBP1-AS1 in the Pathogenesis of Cervical Cancer. Front Oncol. 2021; 11:634732. PMC: 8023048. DOI: 10.3389/fonc.2021.634732. View

15.

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

16.

Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W . Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015; 151:141-51. PMC: 4457591. DOI: 10.1016/j.pharmthera.2015.04.002. View

17.

Geisler S, Coller J . RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013; 14(11):699-712. PMC: 4852478. DOI: 10.1038/nrm3679. View

18.

Wang X, Ding Y, Wang J, Wu Y . Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network. Front Genet. 2020; 10:1398. PMC: 6997565. DOI: 10.3389/fgene.2019.01398. View

19.

Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G . The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2012; 73(3):1180-9. PMC: 3589741. DOI: 10.1158/0008-5472.CAN-12-2850. View

20.

Liu Z, Li M, Hua Q, Li Y, Wang G . Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation. Int J Mol Med. 2019; 44(4):1333-1343. PMC: 6713414. DOI: 10.3892/ijmm.2019.4303. View